LXRX
Lexicon PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
LXRX Profile
Lexicon Pharmaceuticals, Inc.
A company that developing small molecule compounds to treat diabetes and gastrointestinal disorders
Biological Technology
07/07/1995
04/07/2000
NASDAQ Stock Exchange
103
12-31
Common stock
2445 Technology Forest Blvd., 11th Floor , The Woodlands, TX 77381
--
Lexicon Pharmaceuticals, Inc., is a biopharmaceutical company focused on researching and achieving breakthroughs in the treatment of human diseases. Through gene knockout technology and a comprehensive platform of advanced medical technology, the company has systematically studied the physiological and behavioral functions of nearly 5,000 genes in mice, and evaluated the utility of proteins encoded by corresponding human genes as potential drug targets, and has identified and verified more than 100 targets in living (or living organisms) that can be well applied to drug discovery. For those targets that are identified as having high medicinal value, it is committed to the development of potential new drugs. The company was established in Delaware on July 7, 1995, and began operations in September 1995.
